HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adding Zarbee's, J&J Gains Natural Market Footprint, Claims Credibility

This article was originally published in The Rose Sheet

Executive Summary

Zarbee's Naturals vitamin, mineral and dietary supplement products were launched in 2008 by a physician interested in offering non-drug alternative remedies for children and adults for indications such as cough and cold, sore throat, immune support, sleep and digestive health. J&J on the other hand, has been challenged in class action litigation about natural claims it's used on some of its Aveeno and Neutgrogena skin care product labels.

You may also be interested in...



J&J's CEO Gorsky Steps Aside With Duato Named His Successor

J&J's CEO Alex Gorsky is stepping down after almost 10 years in the role and will be replaced by vice chairman of the executive committee Joaquin Duato. 

J&J’s Zarbee’s Natural Business Stung By P&G Challenge To Using ‘Natural’ In Brand Name

NAD recommends qualifying Zarbee’s Naturals brand on packaging when a formulation contains synthetic ingredients. J&J business will comply but disagrees its brand is misleading and says the recommendation is “not based on empirical data from consumers surveys” but NAD attorneys’ intuition.

Maty's Ad Claims Comparing Natural Remedies To OTC Drugs Fail Review From Zarbees Challenge

Maty’s Healthy Products agrees to stop using claims for its children’s and adult cough and cold products after a Zarbees challenge reviewed by National Advertising Division, which found Maty’s made an apples-to-oranges comparison of its supplements to OTC drugs.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS121748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel